EVOLVE扩展研究:vedolizumab和ustekinumab作为克罗恩病的一线生物治疗

{"title":"EVOLVE扩展研究:vedolizumab和ustekinumab作为克罗恩病的一线生物治疗","authors":"Federica Angius","doi":"10.55788/7e9e0353","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":228261,"journal":{"name":"Medicom Conference Report DDW 2023","volume":"133 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease\",\"authors\":\"Federica Angius\",\"doi\":\"10.55788/7e9e0353\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":228261,\"journal\":{\"name\":\"Medicom Conference Report DDW 2023\",\"volume\":\"133 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicom Conference Report DDW 2023\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55788/7e9e0353\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report DDW 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/7e9e0353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}